330 related articles for article (PubMed ID: 26995007)
1. The impact of stage of chronic kidney disease on the outcomes of diabetics with acute myocardial infarction treated with percutaneous coronary intervention.
Vichova T; Knot J; Ulman J; Maly M; Motovska Z
Int Urol Nephrol; 2016 Jul; 48(7):1137-43. PubMed ID: 26995007
[TBL] [Abstract][Full Text] [Related]
2. Chronic kidney disease and diabetes associated with long-term outcomes in patients receiving percutaneous coronary intervention.
Lin MJ; Lee J; Chen CY; Huang CC; Wu HP
BMC Cardiovasc Disord; 2017 Sep; 17(1):242. PubMed ID: 28893175
[TBL] [Abstract][Full Text] [Related]
3. Mortality after percutaneous coronary revascularization: Prior cardiovascular risk factor control and improved outcomes in patients with diabetes mellitus.
Noman A; Balasubramaniam K; Alhous MHA; Lee K; Jesudason P; Rashid M; Mamas MA; Zaman AG
Catheter Cardiovasc Interv; 2017 Jun; 89(7):1195-1204. PubMed ID: 28029209
[TBL] [Abstract][Full Text] [Related]
4. Outcomes of STEMI patients with chronic kidney disease treated with percutaneous coronary intervention: the Malaysian National Cardiovascular Disease Database - Percutaneous Coronary Intervention (NCVD-PCI) registry data from 2007 to 2014.
Ismail MD; Jalalonmuhali M; Azhari Z; Mariapun J; Lee ZV; Zainal Abidin I; Wan Ahmad WA; Zuhdi ASM;
BMC Cardiovasc Disord; 2018 Sep; 18(1):184. PubMed ID: 30249197
[TBL] [Abstract][Full Text] [Related]
5. Percutaneous coronary intervention reduces mortality in myocardial infarction patients with comorbidities: Implications for elderly patients with diabetes or kidney disease.
Dégano IR; Subirana I; Fusco D; Tavazzi L; Kirchberger I; Farmakis D; Ferrières J; Azevedo A; Torre M; Garel P; Brosa M; Davoli M; Meisinger C; Bongard V; Araújo C; Lekakis J; Francès A; Castell C; Elosua R; Marrugat J;
Int J Cardiol; 2017 Dec; 249():83-89. PubMed ID: 29121766
[TBL] [Abstract][Full Text] [Related]
6. Impact of severity of renal dysfunction on determinants of in-hospital mortality among patients undergoing percutaneous coronary intervention.
Parikh PB; Jeremias A; Naidu SS; Brener SJ; Lima F; Shlofmitz RA; Pappas T; Marzo KP; Gruberg L
Catheter Cardiovasc Interv; 2012 Sep; 80(3):352-7. PubMed ID: 22566286
[TBL] [Abstract][Full Text] [Related]
7. The ratio of contrast volume to glomerular filtration rate predicts in-hospital and six-month mortality in patients undergoing primary angioplasty for ST-elevation myocardial infarction.
Çiçek G; Bozbay M; Açıkgöz SK; Altay S; Uğur M; Köroğlu B; Uyarel H
Cardiol J; 2015; 22(1):101-7. PubMed ID: 24671903
[TBL] [Abstract][Full Text] [Related]
8. Prognostic Relation Between Severity of Diabetes Mellitus (On or Off Insulin) ± Chronic Kidney Disease with Cardiovascular Risk After Percutaneous Coronary Intervention.
Chamaria S; Bhatheja S; Vengrenyuk Y; Sweeny J; Choudhury H; Barman N; Mehran R; Sharma S; Baber U; Kini A
Am J Cardiol; 2018 Jan; 121(2):168-176. PubMed ID: 29187288
[TBL] [Abstract][Full Text] [Related]
9. Contrast-Induced Nephropathy in STEMI Patients With and Without Chronic Kidney Disease.
Jain T; Shah S; Shah J; Jacobsen G; Khandelwal A
Crit Pathw Cardiol; 2018 Mar; 17(1):25-31. PubMed ID: 29432373
[TBL] [Abstract][Full Text] [Related]
10. GFR and cardiovascular outcomes after acute myocardial infarction: results from the Korea Acute Myocardial Infarction Registry.
Bae EH; Lim SY; Cho KH; Choi JS; Kim CS; Park JW; Ma SK; Jeong MH; Kim SW
Am J Kidney Dis; 2012 Jun; 59(6):795-802. PubMed ID: 22445708
[TBL] [Abstract][Full Text] [Related]
11. Impacts of chronic kidney disease and diabetes on cardiovascular mortality in a general Japanese population: A 20-year follow-up of the NIPPON DATA90 study.
Hirata A; Okamura T; Sugiyama D; Kuwabara K; Kadota A; Fujiyoshi A; Miura K; Okuda N; Ohkubo T; Okayama A; Ueshima H;
Eur J Prev Cardiol; 2017 Mar; 24(5):505-513. PubMed ID: 27856810
[TBL] [Abstract][Full Text] [Related]
12. Impact of chronic kidney disease on mortality in patients with ST-segment elevation myocardial infarction treated with primary percutaneous coronary intervention. A long-term single-center mortality study.
Peyracchia M; Scacciatella P; Conrotto F; Meynet I; Biava LM; Budano C; Pennone M; D'Amico M; Gaita F
Minerva Cardioangiol; 2018 Feb; 66(1):6-15. PubMed ID: 28948753
[TBL] [Abstract][Full Text] [Related]
13. Impact of chronic kidney disease on clinical outcomes in patients with non-ST elevation myocardial infarction receiving percutaneous coronary intervention - A five-year observational study.
Wang HT; Chen YL; Wu CJ
Int J Cardiol; 2016 Oct; 220():166-72. PubMed ID: 27379919
[TBL] [Abstract][Full Text] [Related]
14. Combined impact of chronic kidney disease and contrast-induced nephropathy on long-term outcomes in patients with ST-segment elevation acute myocardial infarction who undergo primary percutaneous coronary intervention.
Nakahashi H; Kosuge M; Sakamaki K; Kiyokuni M; Ebina T; Hibi K; Tsukahara K; Iwahashi N; Kuji S; Oba MS; Umemura S; Kimura K
Heart Vessels; 2017 Jan; 32(1):22-29. PubMed ID: 27106917
[TBL] [Abstract][Full Text] [Related]
15. Management and Outcomes of ST-Segment Elevation Myocardial Infarction in US Renal Transplant Recipients.
Gupta T; Kolte D; Khera S; Goel K; Aronow WS; Cooper HA; Jain D; Rihal CS; Fonarow GC; Panza JA; Bhatt DL
JAMA Cardiol; 2017 Mar; 2(3):250-258. PubMed ID: 28097322
[TBL] [Abstract][Full Text] [Related]
16. Comparison of Long-Term Mortality in Patients With Single Coronary Narrowing and Diabetes Mellitus to That of Patients With Multivessel Coronary Narrowing Without Diabetes Mellitus.
Omair M; Koshy AN; Dinh DT; Brennan AL; Reid CM; Ajani AE; Duffy SJ; Farouque O; Yudi MB; Clark DJ
Am J Cardiol; 2021 Mar; 142():1-4. PubMed ID: 33285090
[TBL] [Abstract][Full Text] [Related]
17. Incidence, predictors, and outcome of new, subsequent lesions treated with percutaneous coronary intervention in patients presenting with myocardial infarction.
Lemesle G; de Labriolle A; Bonello L; Torguson R; Kaneshige K; Xue Z; Suddath WO; Satler LF; Kent KM; Lindsay J; Pichard AD; Waksman R
Am J Cardiol; 2009 May; 103(9):1189-95. PubMed ID: 19406257
[TBL] [Abstract][Full Text] [Related]
18. Chronic kidney disease predicts atrial fibrillation in patients with ST-segment elevation myocardial infarction treated by primary percutaneous coronary intervention.
Șerban RC; Șuș I; Lakatos EK; Demjen Z; Ceamburu A; Fișcă PC; Somkereki C; Hadadi L; Scridon A
Acta Cardiol; 2019 Dec; 74(6):472-479. PubMed ID: 30650039
[No Abstract] [Full Text] [Related]
19. The dose-response association between estimated glomerular filtration rate and prognosis of patients with ST-segment elevation myocardial infarction from rural areas of China's Liaoning province.
Li G; Qi G; Zhang B; Zhou B; Ma B; Jiang D; He Q; Ai C; Dai H; Li Y; Shi J
Medicine (Baltimore); 2017 Dec; 96(52):e9508. PubMed ID: 29384954
[TBL] [Abstract][Full Text] [Related]
20. Different impact of diabetes mellitus on in-hospital and 1-year mortality in patients with acute myocardial infarction who underwent successful percutaneous coronary intervention: results from the Korean Acute Myocardial Infarction Registry.
Park KH; Ahn Y; Jeong MH; Chae SC; Hur SH; Kim YJ; Seong IW; Chae JK; Hong TJ; Cho MC; Bae JH; Rha SW; Jang YS;
Korean J Intern Med; 2012 Jun; 27(2):180-8. PubMed ID: 22707890
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
